PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Djordje Baletic

University of Novi Sad

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

SEP 3, 2026 · JOURNAL ARTICLE

From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals

Current Medical Research and Opinion

A narrative review synthesizing evidence on pharmacological strategies for type 2 diabetes prevention in obese individuals, grading existing agents by strength of preventive evidence and positioning incretin agonists within the prevention landscape.

Expert GuidanceBranislava Teofilović Aleksandar Rašković Pharmacology and Obesity Treatment

Reported

Global diabetes prevalencemore than 828 million people worldwide

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support